Latest Exploration News

Altair Minerals has revealed a significant 2km gold anomaly at its South Oko Prospect in Guyana, mirroring the geochemical footprint of the nearby $1 billion Oko West deposit. This discovery positions Altair at the forefront of a highly prospective gold belt with promising exploration upside.

Evergreen Lithium has secured rights to two promising gold projects in Western Australia’s premier goldfields, significantly boosting its exploration footprint with minimal upfront cash outlay. The acquisitions position the company to leverage historical data and regional infrastructure as it advances toward becoming a gold producer.

Scentre Group reported a 3.2% rise in Funds From Operations for H1 2025 and upgraded its full-year distribution guidance, driven by record occupancy and retail sales growth across its Westfield portfolio.

Estrella Resources and its partner PT Raka Energi Mandiri have agreed to extend key project milestones for their Werumata limestone venture in Timor-Leste, reflecting internal delays but maintaining a positive outlook.

Neurizon Therapeutics reported a $16.6 million loss for FY2025 amid significant progress in its lead neurodegenerative therapy NUZ-001, including regulatory milestones and a global licensing deal. The company is poised to enter a pivotal ALS clinical trial pending FDA clearance.

Victory Metals secures $11.5 million through a strategic placement to accelerate drilling and development at its North Stanmore heavy rare earth project, reinforcing its position as Australia’s leading rare earths explorer.

True North Copper has significantly extended the mineralised footprint at its Aquila Prospect within the Mt Oxide Project, unveiling multiple new high-quality copper-cobalt-silver drill targets. Drilling is underway to test these promising extensions, potentially reshaping the project’s resource profile.

Kaili Resources has responded to ASX inquiries following volatile trading, confirming imminent rare earth element drilling in South Australia and revealing detailed shareholder data.

Gorilla Gold reports exceptional high-grade drill results extending beyond its recent 350,000-ounce Mulwarrie resource estimate, setting the stage for a significant resource upgrade later this year.

EMVision Medical Devices is set to activate its sixth and final pivotal trial site at UCLA Health, advancing its emu™ brain scanner towards FDA submission. Meanwhile, the Continuous Innovation Study grows with the addition of Box Hill Hospital.

Chrysos Corporation reported a robust FY25 with 46% revenue growth and an 80% jump in EBITDA, driven by expanding adoption of its PhotonAssay technology and a landmark contract with gold giant Newmont. The company projects further growth in FY26 with revenue guidance of $80-90 million.

Ballard Mining reports strong infill and extensional drilling results at its Mt Ida Gold Project, confirming and potentially expanding the high-grade Baldock resource. The ongoing program aims to upgrade resource confidence and supports future development plans.